UroGen Pharma URGN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's free cash flow?
- UroGen Pharma (URGN) reported free cash flow of -$45.37M in Q1 2026.
- How has UroGen Pharma's free cash flow changed year-over-year?
- UroGen Pharma's free cash flow decreased by 7.8% year-over-year, from -$42.07M to -$45.37M.
- What is the long-term trend for UroGen Pharma's free cash flow?
- Over 4 years (2021 to 2025), UroGen Pharma's free cash flow has grown at a 17.4% compound annual growth rate (CAGR), from -$85.64M to -$162.73M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.